De-risking late-stage activities by retaining your early-stage expertise

Nolan Sutherland

28 August 2022

Editorial

Managing variability in autologous apheresis collections

Joseph Roig

22 February 2022

Editorial

Cell and gene therapy approvals soar in the first half of 2021

Christopher A Bravery

20 December 2021

Editorial

Biomanufacturing I-O therapeutics in the 21st century

Gregory Zarbis-Papastoitsis

29 November 2021

Editorial

Adherent versus suspension based platforms: what is the near future of viral vector manufacturing?

Ramin Baghirzade

09 November 2021

Editorial

Improving the yield of rAAV manufacturing with HeLa producer cells lines to ensure patient access

Matthew Fuller

05 October 2021

Editorial

Outlook on manufacturing adoptive cell therapies for cancer immunotherapy

Xiuyan Wang, Isabelle Rivière

21 April 2021

Editorial

Process development: how to win the race in cell & gene therapy

Ramin Baghirzade

04 November 2020

Editorial

Assessing and managing raw material risk

Tom Walls

01 April 2020

Editorial

Need for regulatory compliance in research: what is Good Laboratory Practice and what is a validated assay?

Lincoln Tsang

22 July 2019

Editorial

Process validation for recombinant adeno-associated virus vectors in rare diseases: challenges for MAAs

Catherine Cancian

16 May 2019

Editorial

Manufacturing of genetically modified autologous T cells: key considerations for process development

Mamta Kalra, Ali Mohamed

26 April 2019

Editorial

Critical considerations for allogeneic cell therapy scale up

Sharon Grimster

18 December 2018

Editorial

Update on the Sleeping Beauty transposon system for therapeutic applications

Suneel A Narayanavari

06 December 2018

Editorial

Lentiviral vectors in hematopoietic stem cell therapies: mainstay technology, or simply a bridge to gene editing?

Marc Moore, John R Counsell

30 November 2018

Editorial

Emerging Automated Approaches for Cell and Gene Therapy Manufacture

Qasim Rafiq

20 November 2018

Editorial

Changing the ‘Art’ of Growing Cells into an Industrialized Platform for Commercial-Scale Manufacturing

Lior Raviv

06 November 2018

Editorial

Automation: systems thinking shows the value of manufacturing technology & those who can integrate product & process development

David Williams

27 October 2017

Editorial

Cell and gene therapy: scaling up and moving to mass production

Nigel Whittle

21 April 2017

Editorial

AAV vector and gene therapy: en route for the American dream?

Nathalie Clement

05 December 2016

Editorial